Research suggests GLP-1 medications may reduce certain inflammatory pathways directly, while also lowering inflammation indirectly through weight loss, improved insulin resistance, and reduced visceral fat
In June 2023, The New England Journal of Medicine published Eli Lilly and Company's Phase 2 clinical trial data on Retatrutide (LY3437943) online
Track in log : Note reconstitution dates in journal/app
Examples of FDA-approved peptides: Semaglutide (Ozempic, Wegovy): Approved for: Type 2 diabetes (Ozempic), obesity (Wegovy) Legal status: Prescription required, completely legal Schedule: Not a controlled substance Availability: Through licensed pharmacies with valid prescription Tirzepatide (Mounjaro, Zepbound): Approved for: Type 2 diabetes (Mounjaro), obesity (Zepbound) Legal status: Prescription required, completely legal Recent: Approved 2022-2023 Tesamorelin (Egrifta): Approved for: HIV-associated lipodystrophy (belly fat) Legal status: Prescription required, completely legal Sermorelin, CJC-1295 (with DAC - as Tesamorelin precursor): Some formulations approved for specific conditions Generally require prescription through compounding pharmacies PT-141 (Bremelanotide/Vyleesi): Approved for: Female sexual dysfunction Legal status: Prescription required, completely legal Key point: If a peptide is FDA-approved and you have a legitimate prescription, it's 100% legal
By helping neutralize free radicals and supporting the body's natural antioxidant defenses, it may help reduce oxidative stress that can contribute to skin inflammation
These techniques not only facilitate the analysis but also enhance the accuracy and reduce the time required for results
